A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
Trial ID or NCT#
In this study, patients with advanced solid tumors will undergo [18F]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.
A Pilot Study of Using [18F]F AraG PET Imaging to Evaluate the Immunological Response to Checkpoint Inhibitor Therapy (CkIT) in Patients With Advanced Solid Tumors
- - Solid tumor with planned CkIT - Must be >18 years old - Signed Informed Consent Form - Patient must have two qualifying lesions
- - Patient is pregnant or breast feeding
Contact us to find out if this trial is right for you.
Maria Isabel Galvez Leonio
View on ClinicalTrials.gov